Impact of GLP-1 Agonists on Alcohol Intake

SOURCE www.foxnews.com
Weight-loss medications known as GLP-1 agonists have been shown to reduce alcohol intake, potentially offering a new avenue for managing alcohol use disorder.

Key Points

  • GLP-1 agonists reduce weekly alcohol intake by almost two-thirds
  • GLP-1 receptors in the brain may be a therapeutic target for alcohol use disorder
  • GLP-1 agonists provide a new avenue for managing alcohol use disorder

Pros

  • GLP-1 agonists reduce alcohol intake
  • The medications create 'guard rails' preventing excessive drinking
  • Potential new therapeutic target for alcohol use disorder

Cons

  • Small study size
  • Self-reported alcohol intake
  • Lack of control group